Grant Glatfelter, Ph.D.

Research Interests

Grant C. Glatfelter Ph.D., received his B.S. in Psychology with a minor in Biology from York College of Pennsylvania in 2013. From 2012 – 2014, Grant worked prior to graduate school as a research assistant primarily under Matthew W. Johnson Ph.D. at the Johns Hopkins Behavioral Pharmacology Research Unit, where he assisted various studies administering alcohol, methamphetamine, cocaine, and psilocybin to human volunteers to examine effects on delay discounting measures as well as therapeutic efficacy. Grant next completed his Ph.D. in Pharmacology & Toxicology in the lab of Margarita L. Dubocovich Ph.D. at the University of Buffalo Jacobs School of Medicine and Biomedical Sciences in July 2019, where he studied the neuropharmacology and chronobiological effects of environmental chemicals and novel pharmacological tools acting at melatonin receptors. Currently, Dr. Glatfelter is a postdoctoral fellow in the Designer Drug Research Unit (DDRU) of the National Institute on Drug Abuse Intramural Research Program in Baltimore, MD. Dr. Glatfelter joined the DDRU in the Fall of 2019 and primarily studies the neuropharmacology of emerging new psychoactive substances (NPS) and novel medications of the opioid, cannabinoid, stimulant, and hallucinogen classes under expert mentorship of Michael H. Baumann Ph.D.